British lawmaker, academic and barrister; MP for Torfaen since 2015
AstraZeneca has announced that Wainua, its gene-silencer drug for transthyretin-mediated amyloid cardiomyopathy, did not meet its primary endpoint in a phase 3 trial. The news triggers a sharp stock drop and prompts investors to rethink the company’s long-term growth targets and the strength of its pipeline.
Civil service pension delays after Capita's takeover have left thousands waiting on payments, with some facing rent arrears and food-bank use. The government vows to insource the scheme and enforce improvements as auditors review Capita’s systems.
Labour leader has appointed a top team to drive a new government’s policy agenda. Resignations from key ministers precede the reshuffle, while allies discuss potential high‑profile roles. Burnham’s first Downing Street address signals a period of reflection and a plan for a ten‑year national strategy.
The Guardian and The Scotsman pieces outline Andy Burnham’s task of navigating EU relations and defence co-operation after inheriting Starmer’s reset agenda. Europe signals openness, but wary demands persist as the UK seeks closer ties without rejoining the single market.